Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cortienic Acid, (11alpha,17alpha)-isomer
1. 3597-45-3
2. 81738132xu
3. (8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-17-carboxylic Acid
4. Cortienicacid
5. Unii-81738132xu
6. Schembl1626382
7. Q27269221
8. 11.beta.,17.alpha.-dihydroxy-17.beta.-carboxyandrost-4-en-3-one
9. 17.beta.-carboxy-11.beta.,17.alpha.-dihydroxy-4-androsten-3-one
10. 11.beta.,17-dihydroxy-3-oxo-androst-4-ene-17.beta.-carboxylic Acid
11. 11.beta.,17.alpha.-dihydroxyandrost-4-en-3-one-17.beta.-carboxylic Acid
12. Androst-4-en-17-carboxylic Acid, 11,17-dihydroxy-3-3-oxo,(11beta,17alpha)
13. Androst-4-ene-17-carboxylic Acid, 11,17-dihydroxy-3-oxo-, (11.beta.,17.alpha.)-
14. Androst-4-ene-17.beta.-carboxylic Acid, 11.beta.,17-dihydroxy-3-oxo-
15. (8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-17-carboxylic Acid
| Molecular Weight | 348.4 g/mol |
|---|---|
| Molecular Formula | C20H28O5 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 348.19367399 g/mol |
| Monoisotopic Mass | 348.19367399 g/mol |
| Topological Polar Surface Area | 94.8 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 669 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Cortienic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cortienic Acid, including repackagers and relabelers. The FDA regulates Cortienic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cortienic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cortienic Acid supplier is an individual or a company that provides Cortienic Acid active pharmaceutical ingredient (API) or Cortienic Acid finished formulations upon request. The Cortienic Acid suppliers may include Cortienic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Cortienic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cortienic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Cortienic Acid active pharmaceutical ingredient (API) in detail. Different forms of Cortienic Acid DMFs exist exist since differing nations have different regulations, such as Cortienic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cortienic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Cortienic Acid USDMF includes data on Cortienic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cortienic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cortienic Acid suppliers with USDMF on PharmaCompass.
Cortienic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cortienic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cortienic Acid GMP manufacturer or Cortienic Acid GMP API supplier for your needs.
A Cortienic Acid CoA (Certificate of Analysis) is a formal document that attests to Cortienic Acid's compliance with Cortienic Acid specifications and serves as a tool for batch-level quality control.
Cortienic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Cortienic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cortienic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Cortienic Acid EP), Cortienic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cortienic Acid USP).
LOOKING FOR A SUPPLIER?
